Yang Dong Selected Research

1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)

5/2021	The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
1/2020	Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Dong Research Topics

Disease

68	Neoplasms (Cancer) 05/2024 - 02/2007
20	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2009
15	Osteosarcoma (Osteogenic Sarcoma) 02/2024 - 01/2009
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 09/2017
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 11/2019
5	Infections 01/2023 - 11/2012
5	Fibrosis (Cirrhosis) 12/2022 - 01/2016
5	Carcinoma (Carcinomatosis) 01/2022 - 11/2013
5	Carcinogenesis 01/2022 - 05/2016
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2017
4	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2014
4	Hearing Loss (Hearing Impairment) 12/2023 - 04/2016
4	Triple Negative Breast Neoplasms 10/2022 - 02/2019
4	Hypertension (High Blood Pressure) 03/2022 - 01/2017
4	Breast Neoplasms (Breast Cancer) 05/2021 - 04/2014
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 05/2024 - 03/2011
3	Inflammation (Inflammations) 12/2023 - 06/2011
3	Presbycusis 12/2023 - 01/2013
3	Silicosis 09/2022 - 01/2021
3	Hypoxia (Hypoxemia) 03/2022 - 01/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2017
3	Genomic Instability 03/2021 - 01/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 11/2013
3	Bone Resorption 01/2020 - 03/2016
3	Pain (Aches) 07/2018 - 11/2012
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018 - 01/2015
3	Ototoxicity 11/2014 - 06/2010
2	Glioma (Gliomas) 02/2024 - 07/2021
2	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2020
2	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2019
2	Giant Cell Tumors (Giant Cell Tumor) 10/2023 - 05/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 10/2021
2	Liver Diseases (Liver Disease) 12/2022 - 01/2022
2	Fatty Liver 11/2022 - 01/2022
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2022 - 01/2021
2	Myocardial Infarction 03/2022 - 03/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2022 - 01/2022
2	Erectile Dysfunction 01/2022 - 01/2013
2	Body Weight (Weight, Body) 01/2022 - 11/2019
2	Necrosis 01/2022 - 01/2020
2	Rubella (German Measles) 01/2022 - 10/2020

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2007
14	Biomarkers (Surrogate Marker)IBA 08/2023 - 09/2016
10	RNA (Ribonucleic Acid)IBA 05/2023 - 01/2016
7	Small Interfering RNA (siRNA)IBA 01/2024 - 10/2019
6	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2016
5	Long Noncoding RNAIBA 05/2024 - 01/2017
5	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 09/2011
5	Therapeutic UsesIBA 01/2023 - 01/2010
5	Messenger RNA (mRNA)IBA 01/2022 - 08/2009
4	PlatinumIBA 05/2023 - 01/2019
4	LipidsIBA 11/2022 - 01/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2011
3	Peptides (Polypeptides)IBA 01/2024 - 05/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 03/2018
3	Transcription Factors (Transcription Factor)IBA 11/2023 - 11/2015
3	AlbuminsIBA 07/2023 - 12/2016
3	Caspase 3 (Caspase-3)IBA 10/2022 - 11/2013
3	EnzymesIBA 12/2021 - 09/2016
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2021 - 01/2019
3	Hematoxylin (Haematoxylon)IBA 12/2021 - 01/2019
3	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 05/2021 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2021 - 11/2014
3	erlong zuociIBA 01/2021 - 06/2010
3	Amyloid (Amyloid Fibrils)IBA 01/2021 - 07/2013
3	CollagenIBA 01/2021 - 01/2016
2	Carrier Proteins (Binding Protein)IBA 02/2024 - 01/2016
2	Sincalide FDA Link 01/2024 - 07/2021
2	Matrix Metalloproteinases (MMPs)IBA 12/2023 - 04/2014
2	CreatinineIBA 07/2023 - 08/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2023 - 11/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
2	CurcuminIBA 01/2023 - 11/2013
2	AntioxidantsIBA 01/2023 - 01/2022
2	Small Cytoplasmic RNAIBA 01/2023 - 11/2022
2	AndrogensIBA 01/2023 - 01/2022
2	LigandsIBA 01/2023 - 01/2021
2	Competitive Endogenous RNAIBA 01/2023 - 09/2022
2	2-oxoglutarate 3-dioxygenase prolineIBA 10/2022 - 08/2022
2	Circular RNAIBA 09/2022 - 05/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2013
2	Fibronectins (Fibronectin)IBA 10/2021 - 01/2016
2	IonsIBA 05/2021 - 01/2020
2	CalciumIBA 05/2021 - 01/2020
2	Phosphates (Orthophosphate)IBA 05/2021 - 01/2020
2	siponimodIBA 05/2021 - 01/2020
2	1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)IBA 05/2021 - 01/2020

Therapy/Procedure

22	Therapeutics 05/2024 - 11/2015
17	Drug Therapy (Chemotherapy) 02/2024 - 01/2010
11	Radiotherapy 01/2024 - 01/2014
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023 - 01/2013
3	Immunotherapy 05/2023 - 10/2022
3	Hemoperfusion 11/2019 - 01/2013
3	Prostheses and Implants (Prosthesis) 08/2014 - 01/2010
3	Limb Salvage 11/2012 - 09/2011
2	Curettage 10/2023 - 03/2022
2	Arthroplasty 10/2023 - 03/2016
2	Aftercare (After-Treatment) 09/2021 - 05/2018